Cargando…

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma

INTRODUCTION: Colorectal cancer shows high incidence and mortality rates. Immune checkpoint blockade can be used to treat colorectal carcinoma (CRC); however, it shows limited effectiveness in most patients. METHODS: To identify patients who may benefit from immunotherapy using immune checkpoint inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zhongqing, Sun, Ruolan, Tu, Pengcheng, Liang, Yan, Liang, Li, Liu, Fuyan, Bian, Yong, Yin, Gang, Zhao, Fan, Jiang, Mingchen, Gu, Junfei, Tang, Decai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795839/ https://www.ncbi.nlm.nih.gov/pubmed/36591255 http://dx.doi.org/10.3389/fimmu.2022.944286

Ejemplares similares

Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway
por: Liu, Fuyan, et al.
Publicado: (2022)

Standardized Astragalus Mongholicus Bunge-Curcuma Aromatica Salisb. Extract Efficiently Suppresses Colon Cancer Progression Through Gut Microbiota Modification in CT26-Bearing Mice
por: Gu, Junfei, et al.
Publicado: (2021)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
por: Ding, Lei, et al.
Publicado: (2022)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
por: Huang, Jihong, et al.
Publicado: (2022)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Coagulation- and fibrinolysis-related genes for predicting survival and immunotherapy efficacy in colorectal cancer
por: Ma, Yanling, et al.
Publicado: (2022)

Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma
por: Li, Longqing, et al.
Publicado: (2022)

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies
por: Chen, Lei, et al.
Publicado: (2022)

Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy
por: Huang, Xi, et al.
Publicado: (2023)

An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer
por: Li, Chao, et al.
Publicado: (2023)

The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective
por: Liang, Shuai, et al.
Publicado: (2023)

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
por: Shi, Junhong, et al.
Publicado: (2021)

The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
por: Tu, Jingyao, et al.
Publicado: (2023)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
por: Song, Fei, et al.
Publicado: (2023)

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
por: Gao, Jing, et al.
Publicado: (2022)

Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastases
por: Liang, Huayuan, et al.
Publicado: (2022)

Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
por: Chen, Jinjin, et al.
Publicado: (2022)

Colorectal Cancer Immunotherapy: Options and Strategies
por: Johdi, Nor Adzimah, et al.
Publicado: (2020)

Complement System: An Immunotherapy Target in Colorectal Cancer
por: Talaat, Iman M., et al.
Publicado: (2022)

Mechanism and strategies of immunotherapy resistance in colorectal cancer
por: Shan, Jiqi, et al.
Publicado: (2022)

The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease
por: Ren, Bin, et al.
Publicado: (2021)

Exploration of Different Hypoxia Patterns and Construction of a Hypoxia-Related Gene Prognostic Index in Colorectal Cancer
por: Bai, Shuheng, et al.
Publicado: (2022)

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
por: Chi, Hao, et al.
Publicado: (2023)

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis
por: Zheng, Yang, et al.
Publicado: (2020)

CAR T-cells for colorectal cancer immunotherapy: Ready to go?
por: Ghazi, Bouchra, et al.
Publicado: (2022)

International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
por: Mu, Shidai, et al.
Publicado: (2021)

5-Methylcytosine (m(5)C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis
por: Yin, Haofan, et al.
Publicado: (2022)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers
por: Wu, Gujie, et al.
Publicado: (2023)

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively
por: Tu, Zewei, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis
por: Liang, Xiao, et al.
Publicado: (2022)

Organoid Models for Precision Cancer Immunotherapy
por: Sun, Cai-Ping, et al.
Publicado: (2022)

The cGAS-STING Pathway: A Promising Immunotherapy Target
por: Ou, Liang, et al.
Publicado: (2021)

Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
por: Ghiringhelli, François, et al.
Publicado: (2019)

Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer
por: Hou, Xinxin, et al.
Publicado: (2022)

Immunotherapies catering to the unmet medical need of cold colorectal cancer
por: Yuan, Jun, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
por: Zhou, Long, et al.
Publicado: (2023)

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2022)

Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy
por: Guo, Ziwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_85mmd745plgjbl6tbiklf29u36